GOVERNMENT BUSINESS

Jacobs Wins Contract for the US Army Intelligence and Security Command

Jacobs | August 17, 2021

Jacobs (NYSE:J) was awarded a task order contract by the U.S. Army Intelligence and Security Command (INSCOM) to provide counterintelligence, counterterrorism and human intelligence support to the 902nd Military Intelligence Group at Fort Meade, Maryland. The contract has a value of $235 million over a five-year period.

"Jacobs continues to bolster its cyber and intelligence portfolio with this significant contract, which builds on our longstanding relationship with the U.S. Army and reinforces our commitment to support the mission of the 902nd Military Intelligence Group and INSCOM," said Jacobs Critical Mission Solutions Senior Vice President of Cyber & Intelligence Caesar Nieves. "To meet the continuously evolving threats facing national security, we're harnessing our advanced cyber and intelligence solutions along with our integrated approach and wide-ranging program support capabilities to deliver innovative, mission-focused outcomes that are important to our customers."

As part of the task order, Jacobs will perform work that enables critical sensitive activities in the areas of cyber intrusion damage assessment, geospatial intelligence, language-enabled socio-cultural analysis, digital media forensics and human intelligence targeting.

At Jacobs, we're challenging today to reinvent tomorrow by solving the world's most critical problems for thriving cities, resilient environments, mission-critical outcomes, operational advancement, scientific discovery and cutting-edge manufacturing, turning abstract ideas into realities that transform the world for good. With $14 billion in revenue and a talent force of approximately 55,000, Jacobs provides a full spectrum of professional services including consulting, technical, scientific and project delivery for the government and private sector.

Spotlight

NIDA recently challenged the public to create Infographics that present current scientific information about prescription drug abuse in interesting, novel, and creative ways to help inform and educate the general public. We awarded 3 prizes and over the next several months, the other prize winning graphics will be displayed online. The second place prize went to Shane Jones, Ashley Mentzer, and Adrienne Wolter for their entry Popping Pills: The Prescription Drug Abuse Epidemic in America. The misuse and abuse of prescription medications in the United States remains high, but few people are aware of just how big the problem really is. In its candy-coated hues, this infographic shares the pill popping reality of the situation, from the numbers of abusers to the places they obtain their drugs and their reasons for abusing. With this infographic, their goal was to use the casual spin usually associated with prescription drug abuse – it’s not abuse, it’s just popping pills – to emphasize its seriousness--that prescription drug abuse is a growing problem in the United States today, one that demands our attention.


Other News
EMERGING TECHNOLOGY

Healthera receives funding from Government-backed Innovate UK to tackle critical challenges in the UK pharmacy sector

Healthera | December 02, 2022

Healthera, Cambridge-based digital health platform, today announces that it has been awarded funding from Innovate UK to develop the next generation of innovative patient-pharmacy healthcare platform. Following a rigorous process, and for the 3rd time since 2017, Healthera has been awarded funding from Innovate UK. Healthera has been offered an innovation loan of up to £500,000 to support its ongoing innovation in the community pharmacy and consumer medicine sector throughout the United Kingdom. Innovate UK, the UK's innovation agency sponsored by the Department for Business, Energy and Industrial Strategy, actively supports game-changing and commercially viable R&D projects that can significantly impact the UK economy. About the Project Utilising this new funding and with a strong leadership team with first hand experience in the industry, Healthera is addressing three critical opportunities to 'future-proof' UK pharmacies in this age of rapid digitalisation and growing consumer expectation: Enabling private treatments to be provided by local pharmacies digitally - ensuring safe and local clinical care for millions of patients with conditions like erectile dysfunction and hair loss. Improving medication adherence and access to repeat medication through a combination of smart algorithms, analytics tools, and targeted pharmacist support. Improving speed and accessibility of local delivery for medicines from the largest digital network of pharmacies in the UK. Healthera will leverage its network of over 1500 pharmacies, its current platform and infrastructure, and the clinical training of pharmacists on the platform to help more patients get access to private treatments for conditions that are often left untreated. This will allow local pharmacies to be a part of the rapidly growing sector that was previously only available to online doctors. Innovation from the project also aims to provide accessible delivery options for areas of the UK that do not currently have access to local medicine delivery – and continuing Healthera's original mission to improve adherence of medicines, reduce medicine wastage and spearhead the growth of pharmacy revenue – all this at a time when central funding and revenue channels are being limited for the community pharmacy. "This is an important step in our mission of becoming the go-to health hub for patients. As the market leaders for digitally transforming the pharmacy landscape, we're excited to receive support from Innovate UK to expedite this total innovation and truly future-proof the UK's vital community pharmacy industry." -Quintus Liu, CEO of Healthera. Andrew Bellingham, Director of Product and Strategy at Healthera commented, The pharmacy sector, which I've worked in for 20 years, is well-prepared to enhance their efficiencies, expand to more healthcare verticals, and reach more patients outside of their local vicinity through adopting digital technology. We've identified these opportunities and market gaps and are thrilled to be delivering the support that our invaluable community pharmacies deserve. "We're pleased to offer an innovation loan to Healthera to support the team on their mission to improve the delivery of healthcare through local pharmacies, a large market that is critical for the health of the nation and one that is now becoming ready to be further enhanced through digital innovation. The industry has huge potential for growth and it's important that an innovative platform like Healthera continues to push boundaries." -Scott O'Brien, Director of Innovation Finance at Innovate UK. About Healthera: Founded out of Cambridge University, Healthera operates a market leading healthcare platform that provides patients with medicines, healthcare services and products through the largest digital network of pharmacies in the UK, including over 1,500 pharmacies from large national chains and independent providers. About Innovate UK: Innovate UK is part of UK Research and Innovation, a non-departmental public body funded by grant-in-aid from the UK government. Innovate UK drives productivity and economic growth by supporting businesses to develop and realise the potential of new ideas, including those from the UK's world-class research base.

Read More

EMERGING TECHNOLOGY

Draganfly Selected as Preferred Partner to DEF-C Ukraine Government Military Service Provider

Draganfly | November 18, 2022

Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, is pleased to announce DEF-C, a Ukrainian company involved in the civil and defense sectors, has selected Draganfly as an exclusive provider of drones and related services. DEF-C is a Ukrainian company of the Intecracy Group consortium, which has been involved in projects in the creation and use of unmanned aerial vehicles and solutions in the civil and defense sectors for the past decade, providing a broad range of products and services. Draganfly will provide comprehensive equipment and solutions for emergency response, security, defense, and infrastructure, in addition to mapping, support, and public services. Draganfly’s platforms can adapt to air and ground situations providing a range of solutions that solve integral issues. “DEF-C is a trusted provider to multiple Ukraine agencies. The integration of Draganfly’s solutions into our multiple civil and military projects has been well received, and we look forward to expanding this strategic partnership” -Yuri Syvytsky, Lead Director of DEF-C. The partnership between Draganfly and DEF-C will enable us to continue to provide equipment and solutions to the people of Ukraine, said Cameron Chell, President, and CEO of Draganfly. The selection of Draganfly by DEF-C is a testament to the strength of our technology and our team's ability to provide turnkey solutions that meet the specific needs of our customer base. About Draganfly: Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO; FSE: 3U8) is the creator of quality, cutting-edge drone solutions, software, and AI systems that revolutionize the way organizations can do business and service their stakeholders. Recognized as being at the forefront of technology for over 20 years, Draganfly is an award-winning industry leader serving the public safety, public health, mining, agriculture, industrial inspections, security, mapping, and surveying markets. Draganfly is a company driven by passion, ingenuity, and the need to provide efficient solutions and first-class services to its customers around the world with the goal of saving time, money, and lives.

Read More

EMERGING TECHNOLOGY

Azenta and the Government of Luxembourg Announce a Memorandum of Understanding to Facilitate Continued Healthcare Technology Development

Azenta | November 09, 2022

Azenta, Inc. (Nasdaq: AZTA) and the Government of Luxembourg today announced the signing of a Memorandum of Understanding ("MoU") to facilitate continued healthcare technology development in Luxembourg. The Minister of the Economy of Luxembourg, Mr. Franz Fayot, and the President and CEO of Azenta, Steve Schwartz, signed the MoU at Azenta's Massachusetts-based global headquarters. Azenta, Inc. had recently acquired B Medical Systems, a leading global vaccine, and medical cold chain provider, based in Luxembourg. The MoU signing ceremony was attended by several senior dignitaries from the Ministry of the Economy of Luxembourg, Ministry of Higher Education and Research of Luxembourg, Luxembourg Trade and Investment Office in New York, Luxinnovation and Azenta, Inc. Mr. Luc Provost, CEO of B Medical Systems, and Mr. Jesal Doshi, Deputy CEO of B Medical Systems, represented B Medical Systems, a subsidiary of Azenta, during the ceremony. Confirming Azenta's desire to preserve the production activities of its subsidiary in Luxembourg, B Medical Systems, and to continue the projects undertaken by the subsidiary until then, the memorandum of understanding confirms the intention of the Ministry of the Economy to continue to support the development of the company in Luxembourg. The acquisition by Azenta should also give B Medical Systems access to new markets, thanks to the group's extensive network of customers in countries where B Medical Systems has not previously had a significant presence. The MoU signing ceremony was followed by a visit to Azenta's genomics lab in Waltham, Massachusetts by the delegation of the Ministry of Health led by the Vice Prime Minister and Minister of Health, Ms. Paulette Lenert, and the delegation of the Ministry of the Economy led by the Minister of Economy, Mr. Franz Fayot. "The fact that a world-renowned company such as Azenta has acquired B Medical Systems, one of our industrial flagships, demonstrates the dynamism of the Luxembourg health technology sector, which is one of the pillars of Luxembourg's economic diversification strategy. Through this memorandum of understanding, our objective is to continue the good collaboration that already existed with B Medical Systems, particularly in its future research, development and innovation projects, as well as to identify possible synergies." -Franz Fayot The Minister of the Economy. We look forward to continued partnership and engagement with the Government of Luxembourg. B Medical Systems, which recently became a part of Azenta, has a long history of operations in Luxembourg, and we intend to build upon this already strong track record of growth and innovation, said Steve Schwartz, President and CEO of Azenta. About Azenta Life Sciences: Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Azenta recently acquired B Medical Systems, a leading global vaccine, and medical cold chain provider, based in Luxembourg.

Read More

CYBERSECURITY

Challenges with Data Weaken Cybersecurity Posture for Government Agencies

Splunk | December 15, 2022

Public sector organizations are more likely to struggle with leveraging data to detect and prevent threats than their private sector counterparts (63% to 49%), ultimately affecting their cybersecurity readiness. That’s according to a survey commissioned by Splunk Inc. (NASDAQ: SPLK), the data platform leader for security and observability. The survey found two-thirds (66%) of public sector agencies have difficulties leveraging data to mitigate and recover from cybersecurity incidents and half (52%) of the sector have issues leveraging data to inform cybersecurity decisions. This visibility challenge was also relatively high within the private sector, sharing a similar majority opinion (56% and 50%), showcasing consistency across industries. Another area of concern, both private and public sector respondents noted disparate data sets inhibit agility and real-time response to security events (84% private sector and 56% of public sector). These data challenges also directly impact partnerships between the public and private sectors and their ability to share intelligence. For example, nearly half of public sector organizations (44%) believe the shared intelligence available to them is lacking for their cybersecurity needs. However, both public and private sector organizations agree on three benefits of intelligence sharing: Improved agility (36% public & 44% private) Greater visibility (32% public & 34% private) Targeted preventative and proactive measures (29% public & 23% private) There is also alignment on what is most important to share [insights or information on]: Threat intelligence and actors (69% public and 63% private) Real-time information on security events (60% public and 69% private) Cybersecurity training materials and best practices (79% public and 68% private) Benchmarked data (36% public and 31% private) In light of this, the public and private sectors share similar cybersecurity priorities, including: Improving threat response/remediation (55% public and 53% private) Improving detection of emerging threats (49% public and 47% private) Improving user security awareness (46% public and 50% private) “At the core, security is a data problem and organizations are missing a foundational piece of their security strategy when they cannot leverage their data, All organizations — both private and public — have a responsibility to citizens and customers to enable cyber resiliency and that can be done by having clear visibility and understanding of data. These shared challenges and priorities should translate into better threat intelligence sharing and security practices across all sectors.” -Bill Rowan, VP Public Sector, Splunk. When looking ahead, both public and private sector organizations plan a wide-array of investments to address these cybersecurity priorities. The top investments include: Monitoring/alerting (60% public and 59% private) Threat intelligence (44% public and 46% private), and Security assessments (40% public and 45% private) However, it is important to note private sector respondents are more likely to be planning investments in security orchestration, automation and response (SOAR), centralized log management, and observability. About Splunk, Inc: Splunk Inc. (NASDAQ: SPLK) helps organizations around the world turn data into doing. Splunk technology is designed to investigate, monitor, analyze and act on data at any scale.

Read More

Spotlight

NIDA recently challenged the public to create Infographics that present current scientific information about prescription drug abuse in interesting, novel, and creative ways to help inform and educate the general public. We awarded 3 prizes and over the next several months, the other prize winning graphics will be displayed online. The second place prize went to Shane Jones, Ashley Mentzer, and Adrienne Wolter for their entry Popping Pills: The Prescription Drug Abuse Epidemic in America. The misuse and abuse of prescription medications in the United States remains high, but few people are aware of just how big the problem really is. In its candy-coated hues, this infographic shares the pill popping reality of the situation, from the numbers of abusers to the places they obtain their drugs and their reasons for abusing. With this infographic, their goal was to use the casual spin usually associated with prescription drug abuse – it’s not abuse, it’s just popping pills – to emphasize its seriousness--that prescription drug abuse is a growing problem in the United States today, one that demands our attention.

Resources